Oncology
-
Publication Venue For
- An Intergroup Randomized Phase II Study of Bevacizumab or Cetuximab in Combination with Gemcitabine and in Combination with Chemoradiation in Patients with Resected Pancreatic Carcinoma: A Trial of the ECOG-ACRIN Cancer Research Group (E2204).. 94:39-46. 2018
- Reassessing hepatocellular carcinoma staging in a changing patient population.. 86:63-71. 2014
- Prognostic indicators and treatment outcome in 94 cases of fibrolamellar hepatocellular carcinoma.. 85:197-203. 2013
- Efficacy of bevacizumab plus erlotinib for advanced hepatocellular carcinoma and predictors of outcome: final results of a phase II trial.. 82:67-74. 2012
- I-CLIP: improved stratification of advanced hepatocellular carcinoma patients by integrating plasma IGF-1 into CLIP score.. 80:373-381. 2011
- Safety of bevacizumab in patients with metastatic breast cancer.. 80:314-325. 2011
- Treating primary liver cancer with hepatic arterial infusion of floxuridine and dexamethasone: does the addition of systemic bevacizumab improve results?. 80:153-159. 2011
- Stop and go FOLFOX plus bevacizumab chemotherapy in the first-line treatment of metastatic colorectal cancer.. 79:67-71. 2010
- Bevacizumab improves the overall and progression-free survival of patients with metastatic colorectal cancer treated with 5-fluorouracil-based regimens irrespective of baseline risk.. 75:215-223. 2008